Hematology: Blood, Plasma, and Hemopoiesis
Blood: Basic Properties and Composition
- Blood is a connective tissue with a fluid matrix (plasma) that circulates through heart, arteries, veins, and capillaries, delivering nutrients, electrolytes, hormones, vitamins, antibodies, heat, and oxygen to tissues.
- Normal adult blood volume is about 5 liters (roughly 7–8% of body weight).
- Color ranges from scarlet (oxygen-rich) to dark red (oxygen-poor).
- Temperature: ~38°C (100.4°F).
- pH: 7.35–7.45.
- Salinity (approximate): 85%–90% (as listed in the transcript).
- Blood composition:
- Whole blood: plasma (55%) + formed elements (45%).
- Formed elements include erythrocytes (RBCs), leukocytes (WBCs), and platelets; buffy coat contains leukocytes and platelets (<1% of whole blood).
- Blood volume and composition in numbers:
- Erythrocyte (RBC) volume ~2.5 L (with a typical hematocrit ~0.45 in adults, i.e., 45% RBCs).
- Plasma ~3.0 L (55% of whole blood).
- Formed elements constitute ~45% of blood; RBCs dominate the formed elements (erythrocytes ~99% of formed elements by count).
Plasma and Plasma Proteins
- Composition of plasma (~55% of whole blood):
- Water ~92% of plasma weight.
- Plasma proteins ~7%: Albumins ~58% of plasma proteins, Globulins ~38%, Fibrinogen ~4%, Regulatory proteins <1%.
- Other solutes ~1%: electrolytes, nutrients, gases, wastes, enzymes, hormones, etc.
- Major roles of plasma proteins:
- Albumin: maintains oncotic (osmotic) pressure and helps retain fluid in vessels; transports some ions and substances.
- Globulins: transport lipids and metal ions; include gamma globulins (immunoglobulins/antibodies).
- Fibrinogen: essential for clotting; can be converted to insoluble fibrin.
- Regulatory proteins: enzymes, hormones, etc.
- Plasma is a solvent for formed elements and dissolved solutes; includes electrolytes, nutrients, respiratory gases, and wastes.
- Plasma volume estimate: ~55% of total blood volume; components of plasma are critical for maintaining volume, pressure, pH, and transport functions.
- Erythrocytes (RBCs): biconcave disc, anucleate, no organelles, filled with hemoglobin; life span ~120 days.
- Leukocytes (WBCs): nucleated cells involved in immune defense; major categories include neutrophils, eosinophils, basophils (granulocytes); lymphocytes and monocytes (agranulocytes).
- Platelets (thrombocytes): small cell fragments involved in hemostasis; derived from megakaryocytes.
- Normal counts (typical ranges from the transcript):
- Leukocytes: 4.5–11.0 × 10^3/µL
- Platelets: 150–400 × 10^3/µL
- Erythrocytes: 4.2–6.2 × 10^6/µL
- Formed elements are transported within blood; leukocytes can exit circulation to defend tissues.
- Blood is about 7–8% of body weight; erythrocyte volume contributes ~43% of blood volume (hematocrit around 0.43 in some references; example given: Hct 44% listed in the transcript).
Hemopoiesis (Hematopoiesis): Overview and Sites
- Erythropoiesis: development of red blood cells (RBCs).
- Leucopoiesis: formation of white blood cells (WBCs).
- Granulopoiesis: neutrophils, eosinophils, basophils.
- Monocytopoiesis: monocytes/macrophages.
- Lymphopoiesis: B and T lymphocytes.
- Thrombopoiesis: formation of platelets from megakaryocytes.
- Embryonic and fetal development timeline:
- Begins in the 2nd week of life (embryo) in the yolk sac.
- Fetal liver and spleen are primary sites during mid-gestation.
- By 28 weeks (approximately), red bone marrow becomes the primary hematopoietic site and remains so after birth.
- In the fetus, HbF (fetal hemoglobin) is produced, which has a higher oxygen affinity than adult Hb.
- Blood cells develop from mesenchymal cells called blood islands.
- Postnatally, the red marrow occupies axial skeleton and proximal ends of the appendicular skeleton; active marrow in children is widespread (cranium, ribs, sternum, vertebrae, pelvis, etc.).
- Blood cell formation sites across life:
- Prenatal: yolk sac → liver → spleen → bone marrow (28 weeks onward).
- Postnatal: red bone marrow in axial skeleton (and proximal appendicular regions) predominates.
Hematopoietic Stem Cells and Growth Factors
- Hematopoietic Stem Cells (HSCs): multipotent; reside in bone marrow; give rise to all blood cells.
- Differentiation pathways:
- Myeloid stem cells → RBCs, platelets (thrombocytes), eosinophils, neutrophils, basophils, monocytes/macrophages.
- Lymphoid stem cells → B cells, T cells (and NK cells).
- Growth factors and cytokines control progenitor production:
- Erythropoietin (EPO): stimulates erythrocyte production; produced by kidneys (and a little by liver).
- Thrombopoietin (TPO): stimulates platelet production; originates in liver.
- Colony-stimulating factors (CSFs): stimulate production of granulocytes/macrophages and other leukocytes.
- Granulocyte-macrophage CSF (GM-CSF), Granulocyte CSF (G-CSF), Macrophage CSF (M-CSF).
- Interleukins and other cytokines regulate proliferation and maturation of progenitors.
- Hematopoietic Growth Factors (HGFs) regulate progenitor production; e.g., EPO and TPO.
- Renal function is important for EPO production; renal failure can impair RBC production.
Erythropoiesis: Process, Regulation, and Key Stages
- Erythropoiesis pathway (simplified): Hematopoietic Stem Cell → Myeloid lineage progenitors → Proerythroblast → Erythroblast stages (basophilic → polychromatic → orthochromatic) → Reticulocyte → Erythrocyte.
- Timeline for erythroblast maturation: Phase I–III progression includes ribosome synthesis, hemoglobin accumulation, nucleus ejection, reticulocyte formation.
- Important factors:
- EPO stimulates RBC production; kidneys produce EPO in response to hypoxia.
- Iron, amino acids, and B vitamins (folate, B12) are essential for erythropoiesis.
- Iron transport: transferrin carries iron in blood; ferritin and hemosiderin store iron in liver and bone marrow.
- Iron and heme production: heme synthesis requires iron; heme binds iron at the center of each globin chain to form Hb.
- Reticulocytes emerge after nuclear extrusion and mature into erythrocytes within circulation.
- Lifespan and renewal: RBCs live ~120 days; reticulocytes mature into RBCs in about 1–2 days.
- Regulation and feedback:
- Tissue oxygenation is the single most important regulator of erythropoiesis.
- Negative feedback: rising O2 levels decrease EPO release; hypoxia increases EPO release.
- Testosterone enhances EPO production, contributing to higher RBC counts in males.
- Phases of fetal vs adult erythropoiesis:
- Intrauterine: yolk sac → liver → bone marrow (Myeloid/myelod line predominates in later fetal life).
- Postnatal: primary erythropoiesis in red bone marrow of axial skeleton and girdles; then appendicular sites become active in childhood and taper in adulthood to axial skeleton.
Hemoglobin: Structure, Oxygen Transport, and Variants
- Hemoglobin (Hb) is a tetrameric protein with 4 subunits; adult HbA is α2β2, HbF is α2γ2, HbA2 is α2δ2.
- Each subunit contains a heme group with an iron (Fe2+) ion that binds O2; one Hb molecule can carry up to 4 O2 molecules.
- Normal adult ranges:
- Men: Hb ~13.5–16.5 g/dL
- Women: Hb ~12.1–15.1 g/dL
- Children: ~11–16 g/dL
- Pregnant women: ~11–12 g/dL
- Oxygen transport concepts:
- Oxyhemoglobin: Hb bound to O2; loading occurs in lungs.
- Deoxyhemoglobin: Hb after releasing O2 to tissues.
- Carbaminohemoglobin: Hb bound to CO2; loading occurs in tissues.
- Hb variants and diseases:
- HbS (sickle cell) due to mutations in HBB gene; HbSS, HbSC, HbS/β-thalassemia, etc.
- Iron and heme cycle: after RBC destruction, globin is degraded to amino acids; iron is salvaged by transferrin for reuse; heme is broken down to biliverdin and bilirubin; bilirubin is processed by the liver and excreted in bile; bilirubin metabolism yields urobilinogen, stercobilin, etc.
Erythrocyte Lifecycle and Destruction
- RBCs arise from erythroid precursors in bone marrow and circulate for ~120 days.
- Aging RBCs are phagocytized by macrophages in liver and spleen; globin is recycled to amino acids; iron is salvaged via transferrin; heme is degraded to bilirubin and biliverdin.
- Biliverdin → bilirubin (unconjugated) in liver; bilirubin is conjugated, excreted into bile, then transformed to urobilinogen in the intestine and eventually stercobilin in feces or urobilin in urine.
- Extravascular hemolysis (macrophage-mediated) and intravascular hemolysis (free hemoglobin handling) are managed by haptoglobin, hemopexin, and other proteins to prevent iron loss and toxicity.
- Iron distribution and stores:
- Total body iron ~4 g; 50% in hemoglobin; ~30% stored as ferritin; ~7% in muscles (myoglobin); ~7% in bone marrow; ~25% stored in liver; ~5% in other heme proteins; trace in serum.
- Iron balance and daily losses:
- Non-menstruating individuals lose ~1 mg/day; menstruating women have additional iron losses.
- Absorption: ~10–15% of dietary iron absorbed in mucosal cells; 85–90% excreted.
- Iron transport:
- Transferrin carries Fe3+ in blood; transferrin receptors mediate cellular uptake of iron.
- Transferrin is synthesized in the liver; typically ~95% of serum iron is bound to transferrin, about 30% saturation.
- Iron cycle: iron is stored in ferritin and hemosiderin in liver and spleen; iron is recycled from aged RBCs and transported to bone marrow for erythropoiesis as needed.
- Iron absorption pathways:
- Heme iron (e.g., from animal sources) is absorbed more efficiently than non-heme iron.
- Non-heme iron absorption can be influenced by dietary factors (phytates, tannins, calcium, etc.). Vitamin C/citrate can facilitate absorption.
Blood Volume, Plasma Volume, and Body Water (TBW) Distribution
- Blood volume: ~5 L in a 70-kg adult; about 8% of body weight; equivalently, ~1 mL of blood per g body weight; 5 L is a common reference value.
- Hematocrit (Hct): proportion of blood volume occupied by RBCs; typical ranges:
- Adult males ~42–54%
- Adult females ~38–46%
- Newborns elevated; ranges vary with age.
- Blood volume relationships:
- RBC volume = Hct × total blood volume.
- Plasma volume = total blood volume − RBC volume = total blood volume × (1 − Hct).
- Example from transcript: if BV = 5.5 L and Hct = 0.45, RBC volume ≈ 2.475 L and plasma volume ≈ 3.025 L; equivalently, Plasma Volume = BV × (1 − Hct).
- Total Body Water (TBW) and compartments:
- TBW ~60% of body weight in adults.
- Intracellular fluid (ICF) ~40% of body weight (~0.40 × body weight).
- Extracellular fluid (ECF) ~20% of body weight (~0.20 × body weight).
- ECF subcompartments: Interstitial fluid (~75% of ECF) and Plasma (intravascular, ~25% of ECF).
- Plasma is part of ECF; RBCs/WBCs/platelets are cellular and not included in plasma.
- Specific distributions (for a 70 kg person):
- TBW ≈ 42 L; ICF ≈ 28 L; ECF ≈ 14 L.
- Plasma ~3.0–3.5 L; Interstitial fluid ~11–13 L; Intracellular ~27–30 L.
- Practical implication: most body water is intracellular; about one-third of body water is extracellular, with most of that in interstitial fluid and a portion in plasma.
Regulation of Blood Volume and Fluid Exchange
- Blood volume and osmotic pressure are maintained by negative feedback mechanisms involving:
- Aldosterone (RAAS via kidneys): increases sodium and water reabsorption, expanding blood volume.
- Antidiuretic hormone (ADH, vasopressin): promotes water reabsorption in kidneys, increasing blood volume.
- Atrial natriuretic peptide (ANP) and brain natriuretic peptide (BNP): promote sodium and water excretion by kidneys, reducing blood volume.
- Neural regulation: sympathetic nervous system increases heart rate and causes vasoconstriction during stress, exercise, or blood loss to maintain blood pressure and redirect flow to vital organs.
- Capillary exchange: Starling forces (hydrostatic pressure pushing out; oncotic pressure pulling in) regulate fluid movement between capillaries and interstitial space.
Blood Volume and Clinical Correlates
- Hypovolemia: decreased blood volume due to hemorrhage, dehydration, burns; symptoms include hypotension, tachycardia, reduced organ perfusion; treated with fluid resuscitation.
- Hypervolemia: increased blood volume due to heart/kidney disease or excessive fluids; symptoms include hypertension, edema, dyspnea; treated with diuretics and addressing underlying condition.
- Blood volume measurement methods:
- Indicator dilution: inject tracer and measure dilution to estimate volume.
- Indirect methods: hemoglobin and hematocrit measurements to assess blood volume.
Plasma Proteins and Plasma Chemistry (Table Highlights)
- Plasma protein composition (percent of plasma proteins): Albumins ~58%, Globulins ~38%, Fibrinogen ~4%, Regulatory proteins <1%.
- Albumins and globulins have distinct roles in transport and immune function; fibrinogen is a key clotting factor precursor.
- Plasma electrolytes (typical arterial plasma ranges):
- Sodium Na+ 135–145 mEq/L
- Potassium K+ 3.5–5.0 mEq/L
- Calcium Ca2+ 8.4–10.2 mg/dL
- Chloride Cl− 96–106 mEq/L
- Bicarbonate HCO3− 23.1–26.7 mEq/L
- Phosphate PO4^3− 2.5–4.1 mEq/L
- Hydrogen ion (pH) 7.35–7.45
- Plasma nutrients and metabolites include glucose (fasting 70–100 mg/dL; 2 h post-meal <145 mg/dL), amino acids, lipids (cholesterol 100–200 mg/dL; HDL 40–80 mg/dL; LDL/VLDL 10–100 mg/dL; triglycerides 30–149 mg/dL), phospholipids (6–12 mg/dL).
- Plasma respiratory gases: oxygen and carbon dioxide transported; majority of oxygen bound to Hb inside RBCs; CO2 transported as bicarbonate and bound forms.
- Erythrocytes (RBCs):
- Diameter ~7.5 µm; primary function is transport of O2 and CO2.
- Life span ~120 days.
- Hemoglobin concentration: ~4.8 million/µL for females; ~5.4 million/µL for males.
- Normal WBC count: 4,500–11,000/µL; Platelets 150,000–400,000/µL.
- Morphology: biconcave discs; no nucleus or organelles; spectrin cytoskeleton supports membrane flexibility and shape.
- Leukocytes (WBCs): 5 major types with characteristic functions:
- Neutrophils: 50–70% of WBCs; phagocytosis; respond to histamine; 2–4% eosinophils; 0.5–1% basophils; 20–25% lymphocytes; 3–8% monocytes; lifespan varies from hours (neutrophils) to years (lymphocytes).
- Platelets (thrombocytes): fragments ~2 µm; essential for hemostasis; lifespan ~8–10 days; 150,000–400,000/µL.
- Formed elements proportions in whole blood:
- Plasma ~46–63% (depending on source); formed elements ~37–54%.
- Neutrophils ~65% of WBCs; Lymphocytes ~23%; Monocytes ~5%; Eosinophils ~4%; Basophils ~1%.
Erythrocyte Morphology and Membrane Structure
- RBC membrane contains spectrin and other cytoskeletal proteins that:
- Provide flexibility and enable RBCs to deform as they traverse capillaries.
- Maintain biconcave shape for high surface-area-to-volume ratio, optimizing gas exchange.
- Spectrin mutations underlie hereditary RBC disorders (e.g., hereditary elliptocytosis, hereditary spherocytosis).
- RBCs are nucleate-free and lack organelles; RBCs are filled with Hb; RBCs rely on glycolysis for ATP (anaerobic) to avoid consuming the oxygen they carry.
Blood Gases, Oxygen Transport, and Abnormal Hemoglobins
- Hemoglobin types and expression:
- HbA (α2β2) is the major adult Hb; HbF (α2γ2) has higher oxygen affinity and is predominant in the fetus; HbA2 (α2δ2) is a minor adult Hb.
- Oxygen transport and Hb binding capacity:
- One Hb molecule can bind up to 4 O2 molecules.
- Hemoglobin variants and diseases include HbS (sickle cell), HbC, HbE, etc.
- Diagnostic and clinical notes:
- Anemia: low Hb or RBCs; symptoms include fatigue, pallor, tachycardia.
- Polycythemia: high Hb/Hct; risks include hyperviscosity and clotting.
- CBC and Hb electrophoresis are important diagnostic tools.
- RBC destruction is a multistep process: RBCs become rigid with age, are phagocytized by splenic and hepatic macrophages, and debris is recycled.
- Iron from heme is salvaged via transferrin and ferritin; heme is converted to biliverdin and then bilirubin, which is conjugated in the liver and excreted in bile.
- Bilirubin processing involves transport by albumin to the liver; conjugated bilirubin is excreted into bile and converted to urobilinogen in the intestine; urobilinogen may be reabsorbed or excreted as stercobilin in feces or urobilin in urine.
- Free intravascular hemoglobin is managed by haptoglobin and hemopexin to prevent iron loss and toxicity; methemalbumin and other complexes may form.
- Primary regulator: tissue oxygenation. Hypoxia triggers EPO release from kidneys, stimulating RBC production in bone marrow.
- Negative feedback: rising hematocrit and O2-carrying capacity reduce EPO production.
- Hormonal control: EPO, TPO, CSFs, ILs, and other cytokines regulate lineage commitment and maturation.
- Iron regulation is essential for Hb synthesis; iron stores are tracked via ferritin; transferrin delivers iron to developing erythrocytes; insufficient iron leads to microcytic, hypochromic anemia.
- Vitamins important for erythropoiesis: Vitamin B12 (cobalamin) and folate (folic acid) required for DNA synthesis; iron is essential for heme synthesis; B12 and folate deficiencies cause macrocytic anemias.
- Vitamin B12 and folate participate in DNA synthesis; deficiencies cause megaloblastic anemia; intrinsic factor from the stomach is needed for B12 absorption.
- Iron metabolism overview:
- Dietary iron is absorbed in intestinal mucosa; heme iron has higher bioavailability than non-heme iron.
- Iron is transported in the plasma bound to transferrin; transferrin saturation is used to assess iron status.
- Iron storage occurs as ferritin and hemosiderin in liver, spleen, and bone marrow.
- The iron cycle includes dietary absorption, transport by transferrin, storage, recycling from senescent erythrocytes, and systemic losses.
- Key regulatory substances in erythropoiesis:
- EPO, TPO, G-CSF, GM-CSF, M-CSF, IL-3, IL-7, IL-11, IL-4, IL-2, etc., coordinate proliferation and differentiation of progenitors.
Plasma and Interstitial Fluid: Electrolytes, Osmolarity, and Homeostasis
- Plasma contains electrolytes, nutrients, gases, and wastes; maintains osmotic balance and pH.
- Major intracellular and extracellular fluid compartments:
- Intracellular fluid (ICF): ~2/3 of total body water; located inside cells.
- Extracellular fluid (ECF): ~1/3 of total body water; includes interstitial fluid and plasma.
- Plasma osmotic and hydrostatic forces influence fluid exchange across capillaries (Starling forces).
- Key indices and their typical ranges:
- MCV (Mean Corpuscular Volume): average volume of a single erythrocyte; normal range ~74–95 μm^3 (fL).
- Formula: ext{MCV} = rac{ ext{Hct} imes 10}{ ext{RBC count (million/µL)}}
- MCH (Mean Corpuscular Hemoglobin): average Hb per RBC; ext{MCH} = rac{ ext{Hb (g/dL)} imes 10}{ ext{RBC count (million/µL)}}
- MCHC (Mean Corpuscular Hemoglobin Concentration): average Hb concentration per RBC volume; ext{MCHC} = rac{ ext{Hb (g/dL)}}{ ext{Hct (as a fraction)}}
- Hematocrit (Ht): proportion of blood volume occupied by RBCs; normal ranges vary by age and sex (adult males ~42–54%, adult females ~38–46%).
- RBC count: typically 4.2–6.2 × 10^6/µL; WBC count: 4.5–11.0 × 10^3/µL; Platelets: 150–400 × 10^3/µL.
- Hematocrit and RBC indices are used to classify anemias and assess RBC production/destruction balance.
Blood Products and Transfusion Context
- Blood products include:
- Whole blood; packed red blood cells; leukocyte-poor red cells; washed red cells; platelet concentrates; fresh frozen plasma (FFP); cryoprecipitate; factor concentrates (VIII, IX); albumin; immune globulins.
- Blood components can be stored in specialized conditions (e.g., FFP, platelets) with various shelf lives and handling requirements.
Practical Applications and Real-World Relevance
- Blood doping and EPO: Athletes may attempt to increase RBC mass via autologous transfusion or pharmaceutical EPO, risking increased blood viscosity and cardiovascular complications.
- Anemia and polycythemia: Clinical syndromes with broad etiologies (iron deficiency, chronic disease, marrow disorders, B12/folate deficiency; high altitude adaptation; bone marrow failure; hemolysis).
- Sickle cell disease (HbS) and other Hb variants can lead to hemolytic anemia, vaso-occlusive crises, and organ damage; electrophoresis and genetic testing aid diagnosis.
- Understanding RBC production, iron metabolism, and plasma physiology informs treatments (iron supplementation, EPO therapy, transfusion, chelation in iron overload, etc.).
- Blood volume estimation (example):
- For a 70 kg adult, BV ≈ 5 L (typical reference value).
- RBC and plasma volumes from BV and Hct:
- ext{RBC volume} = ext{BV} imes ext{Hct}
- ext{Plasma volume} = ext{BV} imes (1 - ext{Hct})
- Hematocrit definition:
- ext{Hct} = rac{ ext{RBC volume}}{ ext{BV}}
- Mean Corpuscular Volume (MCV):
- ext{MCV} = rac{ ext{Hct} imes 10}{ ext{RBC count (in millions/µL)}} ext{ (fL)}
- Mean Corpuscular Hemoglobin (MCH):
- ext{MCH} = rac{ ext{Hb (g/dL)} imes 10}{ ext{RBC count (in millions/µL)}} ext{ (pg)}
- Mean Corpuscular Hemoglobin Concentration (MCHC):
- ext{MCHC} = rac{ ext{Hb (g/dL)}}{ ext{Hct (as a fraction)}} ext{ (g/dL)}
Connections to Foundational Concepts
- Homeostasis: Regulation of blood volume, pH, osmolarity, and temperature demonstrates core physiological homeostasis principles.
- Gas exchange and transport: Hb's structure-function relationship underpins oxygen delivery and CO2 removal.
- Immune defense: WBC subtypes and plasma immunoglobulins are central to host defense and inflammation.
- Bone marrow physiology: Hemopoiesis exemplifies how growth factors, cytokines, and niche environments drive stem cell differentiation and lineage commitment.
- Pathophysiology linkages: Anemia, polycythemia, thalassemias, sickle cell disease, and iron disorders illustrate how molecular changes manifest as clinical phenotypes.
Ethical and Practical Implications
- Blood transfusion practices require ethical considerations of donor consent, storage safety, and risk-benefit analyses.
- Blood doping raises ethical concerns and health risks; medical supervision is essential for any therapeutic use of EPO or transfusion in sports.
- Access to blood products and anemia therapies involves public health policy, resource allocation, and patient safety considerations.
- Table 18.1: Physical characteristics and normal values for whole blood components (color, volume, viscosity, plasma concentration, pH, temperature).
- Table 18.2–18.6: Composition of plasma, formed elements, and substances influencing hemopoiesis (growth factors, hormones, and lineage pathways).
- Figures: Schematics of blood components, erythropoiesis stages, and TBW compartments (IBC, ECF, plasma, interstitial fluid).
- Important note: Some typographical errors exist in the source (e.g., “2th week” = 2nd week; various spacing issues). The intended meaning aligns with standard hematology texts.
Summary
- Blood consists of plasma and formed elements; its composition enables transport, immune defense, and hemostasis.
- Hemopoiesis is a tightly regulated process starting in the yolk sac during fetal life and transitioning to the red bone marrow after birth, controlled by growth factors like EPO and TPO.
- Erythrocytes are specialized for gas transport; their production, lifecycle, and destruction are closely linked to iron metabolism and Hb synthesis.
- Iron metabolism, transferrin transport, ferritin storage, and heme catabolism are tightly coordinated to sustain erythropoiesis and prevent iron deficiency or overload.
- TBW distribution and fluid regulation rely on capillary forces, RAAS/ADH/ANP hormonal axes, and cellular compartments to maintain homeostasis.
- Understanding these concepts supports clinical practice in diagnosing and treating anemia, polycythemia, transfusion decisions, and metabolic disorders affecting blood and fluid balance.